banner ad

Hematology (Haematology or Blood) Expert Witnesses

Sort Non-Featured Profiles by
Check for SynapsUs
Sanjiv Modi, MD
1211 S. Prarie Ave.
Unit 4901
Chicago IL 60605
phone: 312-450-2475
fax: 866-597-9162
Sanjiv Modi, MD, is board certified in Medical Oncology, Hematology, and Internal Medicine. In active practice since 2000, Dr. Modi has been reviewing medical records for peer review, utilization review, disability review, and medical legal purposes since 2012. He holds an active Florida Expert Witness Certificate.

Litigation Support - Dr. Modi provides expert witness services for litigation in the specialty of Hematology, Medical Oncology, and Internal Medicine. His services are available to attorneys representing both Plaintiff and Defendant.

Dr. Modi has been called upon to define applicable standards of care and identify deviations from and adherence to the applicable standards of care. He utilizes objective evidence of standards of care and national published guidelines in preparing his reports.

Dr. Modi is familiar with court proceedings and the deposition process. He is experienced in trial and able to communicate with a jury in easy to understand language. His service include medical chart review, narrative reports, and testimony for court, arbitrations and medical panels.

Areas of Expertise:
  • Blood Clots
  • Anticoagulation
  • Cancer
  • Chemotherapy
  • Mesothelioma
  • Clinical Genetics
  • Hospice and Palliative Care
View Dr. Modi's Consulting Profile.
Check for SynapsUs
Arnold D. Berliner, MD, MPH
6721 Serena Ln.
Boca Raton FL 23433
phone: 561-289-2647
Arnold D. Berliner, MD, MPH, is Certified in Internal Medicine, Hematology, and Medical Oncology. Dr. Berliner has extensive clinical experience in cancer management and care of patients with hematologic disorders. He was formerly on the faculty at University of Miami, Miller School of Medicine/Jackson Memorial Hospital. Currently, he is a voluntary teaching associate at Schmidt School of Medicine at Florida Atlantic University in Boca Raton, Florida.

Litigation Support - Dr. Berliner offers case review of Oncology / Hematology involving questions of Delayed Diagnosis and Standard of Care. His services are available to counsel representing both Plaintiff and Defense.

Dr. Berliner opines on matters of:
  • Medical Misdiagnosis
  • Treatment Delay
  • Medical Mismanagement
  • Prostate and AIDS-related Cancers
  • Lymphomas
  • Leukemia
  • Bleeding and Clotting
  • Bone Marrow Transplant
  • Curriculum Vitae Available Upon Request.
    Check for SynapsUs
    Dr. Robert E. Burdick, MD
    2201 39th Ave E.
    Seattle WA 98112
    phone: 206-329-5948
    Robert E. Burdick, MD, is a Board Certified Medical Hematologist and Oncologist with over 40 years of academic, clinical, and expert witness experience. Trained at the University of Washington, he is licensed in the state of Washington and maintains a faculty position at the University of Washington as an Associate Clinical Professor of Medicine.

    In addition to having a broad base of experience with both private practice and academic medicine, he is current with medical literature pertaining to his expertise. His experience includes chemotherapy drug trials, collaboration with surgeons, radiation therapists, and bone marrow transplantation subspecialists and the allied fields of radiation therapy, surgical oncology, diagnostic radiology, and surgical pathology.

    Dr. Burdick is knowledgeable about solid tumors such as cancer of the breast, lung, colon, thyroid, tongue, larynx, head and neck, esophagus, stomach, colon, rectum, anus, skin, melanoma, liver, kidneys, bladder, pancreas, ovary, testicle, hepatoma, and sarcoma, as well as soft tissue malignancies such as non-Hodgkin's and Hodgkin's lymphoma, the acute and chronic leukemia's, multiple myeloma, anemias, leukopenia, thrombocytopenia, and pancytopenia.

    Robert Burdick has over 30 years of experience in the medical-legal arena with expertise in evaluating deviations from the standard of practice for both plaintiffs and defendants. He has testified in 30 to 50 depositions and 8 to 10 trials. He is able to project credibility, explain complex medical issues in easily understood terms, and has the poise and demeanor to withstand the rigors of cross-examination while defending those opinions.

    Dr. Burdick is articulate in both oral or written form, and writes a clear, concise and ethical opinion supported by the premise of evidence based medicine. His opinions are prompt and he will state clearly whether he believes the standard of care has been violated, causation, and the degree of damages the claimant has sustained.

    Areas of Expertise:
    • Anemia
    • Aplastic Anemia
    • Blood Disorders
    • Bone Cancer
    • Breast Cancer
    • Cancer Causation
    • Cancer Therapies
    • Causation Analysis
    • Cervical Cancer
    • Colon Cancer
    • Delay in Diagnosis
    • Hematology

  • Hemophilia
  • Hodgkin's Disease
  • Kidney Cancer
  • Laryngeal Cancer
  • Leukemia
  • Leukodystrophies
  • Liver Cancer
  • Loss of Life Expectancy
  • Lung Cancer
  • Lymphoma
  • Medical Malpractice
  • Medical-Legal Issues

  • Melanoma
  • Myeloma
  • Myeloproliferative Disorders
  • Neutropenia
  • Oncology
  • Oral Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Standard of Care
  • Testicular Cancer
  • Thrombosis
  • 9/30/2014 · Medical
    "Has the standard of care been violated?" is the basic question in all medical malpractice cases, the answer to which may be difficult to determine because the standard of care is often unwritten, can be ever changing, and is a blend of academic and private practice opinions. In addition to having a broad base of experience with both private practice and academic medicine the expert witness must be current with the medical literature, knowledgeable about solid tumors such as cancer of the breast, lung, colon, thyroid, tongue, larynx, head and neck, esophagus, stomach, colon, rectum, anus, skin, melanoma, liver, kidneys, bladder, pancreas, ovary, testicle, hepatoma, and sarcoma, as well as soft tissue malignancies such as non-Hodgkin's and Hodgkin's lymphoma, the acute and chronic leukemia's, multiple myeloma, anemias, leukopenia, thrombocytopenia, and pancytopenia.

    Check for SynapsUs
    Dr. Mark Levin
    6 Gel Court
    Monsey NY 10952
    phone: 845-406-2183
    Dr. Mark Levin, MD, is an Academic Physician with a wide range of experience in various practice settings, including academia, teaching hospital and private practice settings. He has a consulting practice in clinical standards and utilization review in Oncology and runs a blog devoted to Standards of Care. He is in active medical practice.

    Services Include:
    • Administrative Medicine
    • Brain Tumors
    • Breast Cancer
    • Cancer - Missed Diagnosis
    • Chemotherapy
    • Experimental / Investigational Medicine
    • Hematology
    • Improper Diagnosis
    • Kidney Cancer
    • Lung Cancer
  • Medical Practice Guidelines
  • Medical Records Review
  • Medical Utilization Review
  • Mesothelioma and other Asbestos Lung Diseases
  • Oncology
  • Pain Management
  • Prognosis (Cancer)
  • Standard of Care
  • Tumor Marker Testing
  • 12/26/2012 · Robots & Robotics
    Safe and effective chronic opioid therapy for chronic cancer related pain requires clinical skills and knowledge in both the principles of opioid prescribing and on the assessment and management of risks associated with opioid abuse, addiction, and diversion.

    Breast cancer patients often suffer menopausal symptoms, which include vaginal dryness. This distressing symptom is often treated with topical estrogen or progesterone creams; however, there remains a concern about systemic absorption of estrogen and its effect on breast cancer. In a group that is treated with tamoxifen, it would appear that the systemic affect would be negated by the tamoxifen's anti-estrogen blockade but the question remains hotly debated.

    4/3/2009 · Medical
    Breast cancer is a malignant (cancerous) growth that begins in the tissues of the breast. Over the course of a lifetime, one in eight women will be diagnosed with breast cancer

    9/23/2008 · Medical
    Acceptance and compliance with screening and genetic programs for genetic illness depends crucially on the compatibility and fit of their design with the social, cultural and religious concerns and mores of target communities. As a case in point, genetic screening programs that are currently in use within Jewish populations are considered on the background of ethical and religious concerns

    Check for SynapsUs
    Rhonda Grallnick, R.N., B.S.N.
    790 Penllyn Pike
    Suite 105
    Blue Bell PA 19422
    phone: 800-666-7045 or 800-355-1329/610-941-3980
    fax: 215-653-7382

    Medical Advisors Technical Network

    Since 1983, Medical Advisors, Inc. / Technical Network Consulting Service has assisted in the selection of experts in several thousand cases. Working with plaintiff and defense bar, we have provided opinions and testimony which have resulted in competent preparation and in-court support for cases involving scientific, technical, engineering matters as well as medical malpractice, hospital negligence, personal injury, workers’ compensation, product liability and nursing homes. A detailed telephone consultation explores all aspects of your case. This simplifies the job of finding the right expert.
    Check for SynapsUs
    Judy L. Schmidt
    MD, FACP
    100 Hau’oli St.
    Wailuku HI 96793
    phone: 808-281-5189
    Judy Schmidt Hematology Oncology Expert PhotoJudy L. Schmidt, MD, FACP is triple board certified in Internal Medicine, Hematology, and Medical Oncology. She received her Hematology / Medical Oncology training at the Mayo Clinic from 1985 to 1988.

    Dr. Schmidt has been a very active member of ASCO (American Society of Clinical Oncology) including numerous positions associated with Medicare and Quality Cancer Care. In 1999, she was invited by ASCO to testify in Washington, DC for a senate subcommittee on Quality Cancer Care, hosted by Senators Diane Feinstein and Connie Mack.

    Dr. Schmidt's Hematology / Oncology Montana clinic also helped ASCO develop the parameters by which Quality Cancer Care is now measured. She was a Beta member of the ASCO Quality Oncology Practice Initiative (QOPI) participating in the development of the Quality Cancer Care QOPI standard measures of oncology practice quality. More than 700 Medical Oncology practices in the United States now measure their Oncology practice Quality via QOPI standards.

    Dr. Schmidt and her head nurse, Joni Landes RN OCN, received the Professionals of the Year award for quality patient care in 1999 from Coping Magazine. She also received the Mayo Clinic's award for Quality Cancer Care in 2004.

    Dr. Schmidt has provided litigation support services to attorneys for Plaintiff and Defense for over 20 years. She has been retained approximately 40 times and has been an expert Medical Witness for 18 medical malpractice cases since 2010. Dr. Schmidt has reviewed cases for Medical Malpractice Attorneys in Alaska, Arizona, Connecticut, Illinois, Missouri, Montana, New York, Texas and the United Kingdom.

    Areas of Expertise:
    • Delayed Diagnosis of Cancer
    • Failure to Follow Established Clinical Guidelines
    • Adverse Drug Side Effects
    • Failure to Follow Chemotherapy and Radiation Therapy Guidelines
    • Informed Consent
    • Analysis of Medical Errors on Patient Quality of Life
    View Dr. Schmidt's Consulting Profile.
    9/8/2014 · Medical
    The cause of platelet agglutination in thrombotic thrombocytopenic purpura has been an enigma. Current evidence indicates that the interaction of platelets with a platelet-aggregating factor or unusually large multimers of factor VIII:von Willebrand factor, or both, may cause the abnormal platelet agglutination. Recent success in the treatment of thrombotic thrombocytopenic purpura with intravenous infusion of immunoglobulin suggests that the abnormal platelet agglutination in thrombotic thrombocytopenic purpura may reflect a deficiency of immunoglobulins that normally inhibit platelet-aggregating factors or large multimers of factor VIII:von Willebrand factor.

    8/6/2014 · Medical
    Thromboembolism (TE) is a well-known complication in neurosurgical patients and in patients with brain tumors. Estimates of postoperative TE range from 25 to 33% in general surgical patients and from 45 to 70% in patients who have undergone total hip replacement.1 The incidence of deep venous thrombosis (DVT) and pulmonary embolism in neurosurgical patients is similar to that in high-risk surgical patients. The incidence of DVT ranges from 9 to 50% and of fatal pulmonary embolism from 1.5 to 3%.2 The incidence of TE in patients with glioma varies from 36.7% in patients who receive no antithrombotic prophylaxis to 10% in those who receive intermittent pneumatic compression to the calves.3 The current study was undertaken to explore, in patients with high-grade glioma, the associations between TE and factors potentially related to an increased or decreased risk of occurrence of TE.

    Check for SynapsUs
    Clinton F. Merrill, Jr., MD
    118 Mountain Air Dr.
    Laramie WY 82070
    phone: 308-225-3954
    Clinton F. Merrill, Jr., MD, has over 35 years of experience in clinical Internal Medicine and 28 years of experience in Medical Oncology and Hematology.

    Dr. Merrill is experienced in the diagnosis and treatment of all solid tumors as well as the full range of hematologic malignancies. He has special expertise in benign hematology including: anemias, low blood cell counts, iron overload disorders, bleeding and clotting disorders.

    Litigation Support - Dr. Merrill offers expert witness services to counsel representing Plaintiff and Defendant. His services include medical record review, written reports, depositions, and trial testimony. Dr. Merrill takes pride in providing thorough record review, meticulously researched reports reflecting unbiased opinions, and excellent communication skills with the ability to make the complex understandable.

    Areas of Expertise:
    • Breast Cancer
    • Colon Cancer
    • Lung Cancer
    • Tumors
    • Leukemias
    • Lymphomas
  • Myeloma
  • Myeloproliferative Disorders
  • Myelodysplastic Syndromes
  • Benign Hematology
  • Anemia
  • Bleeding and Clotting Disorders